Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
2(18%)
Results Posted
14%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
3
27%
Ph not_applicable
6
55%
Ph phase_1
2
18%

Phase Distribution

2

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
3(27.3%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Terminated1
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
87.5%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (18.2%)
Phase 23 (27.3%)
N/A6 (54.5%)

Trials by Status

terminated19%
active_not_recruiting19%
enrolling_by_invitation19%
recruiting19%
completed764%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
11